Prescription drug · ANDA
Lexette (Halobetasol propionate) NDC 51862-618
Halobetasol propionate .5 mg/g · Aerosol, Foam · Topical · Mayne Pharma
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51862-618-50 | 51862061850 | 1 CANISTER in 1 CARTON (51862-618-50) / 50 g in 1 CANISTERMarketed from Aug 8, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lexette
- Generic name (nonproprietary)
- halobetasol propionate
- Active ingredients
- Halobetasol propionate — .5 mg/g
- Dosage form
- Aerosol, Foam
- Route
- Topical
- Labeler
- Mayne PharmaNDC labeler code 51862
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215266
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 51862-618_8aa1f819-c81f-4af1-aaa7-353df3203ff6SPL ID 8aa1f819-c81f-4af1-aaa7-353df3203ff6SPL set ID 8aa1f819-c81f-4af1-aaa7-353df3203ff6RxCUI 2047646, 2106585UNII 91A0K1TY3Z
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451862061850followed by a unit qualifier and the quantityPackage 51862-0618-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LEXETTE ® is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. LEXETTE is a corticosteroid indicated for the topical treatment of plaque psoriasis in patients twelve (12) years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 51862-618
- What is NDC 51862-618?
- 51862-618 is the product NDC for Lexette (halobetasol propionate), Halobetasol propionate .5 mg/g aerosol, foam, listed with the FDA by Mayne Pharma. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lexette (Halobetasol propionate).
- What is the active ingredient?
- Halobetasol propionate.
- Who is the labeler?
- Mayne Pharma, NDC labeler code 51862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lexette?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 215266
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Halobetasol propionate | Halobetasol propionate .5 mg/g | Aerosol, FoamTopical | Mayne Pharma | 68308-769 |